Upgrade to SI Premium - Free Trial

Medifast (MED) Misses Q3 EPS by 2c, Q4 Guidance Falls Well Short of Consensus

November 7, 2019 4:28 PM
Medifast (NYSE: MED) reported Q3 EPS of $1.32, $0.02 worse than the analyst estimate of $1.34. Revenue for the quarter ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Earnings Guidance Hot Guidance

Next Articles